Disclosure Plus

Exchange Requests Disclosure from AprilBio Co.,Ltd. Regarding 'Rumors of TaekwangIndustrial Takeover'

KIM SAE-MI
2026-06-24 16:45:03
AprilBio Co.,Ltd. CI (Photo courtesy of AprilBio Co.,Ltd.)

[Edaily Reporter KIM SAE-MI ] The KOSDAQ Market Division of the Korea Exchange announced on the 24th that it has requested a disclosure notice regarding rumors of TaekwangIndustrial’s acquisition of AprilBio Co.,Ltd.(397030).

The deadline for a response is 12:00 p.m. on the 25th.

Economy

Corporation

IT·Science

Economy

High Interest Rates and Deteriorating Creditworthiness: A ‘Double Whammy’… Warning Signs as 23 Companies Face Rating Downgrades

As the prolonged period of high interest rates increases the refinancing burden on companies, warning signs of credit rating downgrades have emerged, particularly in sectors experiencing sluggish busi…
2026-11-20 16:10:05

Corporation

"From Longer Ankle Boots to Suede and Block Heels"... This Year's Fall/Winter Shoes Emphasize Materials and Silhouettes

In this year’s fall/winter (FW) footwear market, products that combine warmth and style are gaining attention. The selection of sheepskin boots has expanded, ranging from short styles that cover the a…
2026-11-20 16:37:41

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02